Delivery Order SPE2DB22D2214-SPE2DB25FS6KR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,792.21 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a delivery order valued at $2,789.31 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. Kerendia is a branded pharmaceutical product used in the treatment of chronic kidney disease, representing a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,593.24 on August 20, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, representing the type of...
- The Defense Logistics Agency awarded a $1,511.98 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Kerendia 10 mg tablets (30-count package). This firm fixed-price, non-set-aside contract is scheduled for completion by August 11, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a medication used in the treatment of chronic kidney disease and related conditions, representing a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $1,270.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) valued at $3,603.95. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2.27K delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count units) on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed-price, non-set-aside contract represents a direct award under competitive procurement procedures and will be performed at the contractor's Conshohocken, Pennsylvania facility. Kerendia is a prescription medication used in the treatment of chronic kidney disease, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $2,409.10. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The prime...
- The Defense Logistics Agency awarded a delivery order valued at $9,571.07 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Kerendia 10 mg tablets (quantity: 30 units) at a ceiling value of $3,987.33. This firm fixed-price delivery order, which has an ultimate completion date of May 13, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6KRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,760.59 and an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Kerendia is a brand-name pharmaceutical used in the treatment of chronic kidney disease, reflecting the Defense Logistics Agency's ongoing procurement of specialized medications to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare customers worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to meet federal medical procurement requirements through open competition across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/3/25 |